Histological and qPCR analyses revealed that CYP2E1 inhibition alleviated hepatic steatosis, inflammation, and fibrosis in USP14-overexpressing mice (Fig. 7H–J; Fig. S7E). Here, USP14 is linked to fatty liver disease.